Type 2 Diabetes Trial, By Invitation NCT07248891 Sponsor: Coordinación de Investigación en Salud, Mexico Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, By Invitation

NCT07248891
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults aged 18 years or older.
  • People who have been diagnosed with Type 2 Diabetes.
  • People who receive their care at Family Medicine Units in the Mexican states of Coahuila, Jalisco, or Veracruz.
  • People who are willing to take part in the study voluntarily.
  • People who are able to understand what the study involves and sign a written consent form.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are pregnant or currently breastfeeding.
  • People who are currently taking steroid medications.
  • People who have a condition involving inflammation or the immune system, such as rheumatoid arthritis, lupus, multiple sclerosis, psoriatic arthritis, or gout.
  • People who have used tobacco products in the last 3 months.
  • People who have a history of stroke, heart failure, or kidney failure that required a hospital stay in the past month.
  • People who have had an infection in the past 10 days, such as a respiratory infection, stomach bug, urinary tract infection, or a skin or tissue infection.
  • People with severe obesity (a body mass index over 40), or who have previously had weight-loss (bariatric) surgery.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Coordinación de Investigación en Salud, Mexico
Registry
ClinicalTrials.gov
Start date
1 April 2025
Est. completion
30 December 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇲🇽 Mexico

Primary endpoints

Glycemic control (% HbA1c); Diabetic Nephropathy (eGFR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov